| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Revenue | $431.7M | +9.0% |
| Cost of Revenue | $147.0M | -4.1% |
| Gross Profit | $284.7M | +17.2% |
| R&D Expense | $108.3M | +5.6% |
| SG&A Expense | $74.6M | -5.4% |
| Operating Income | -$64.4M | +65.6% |
| Interest Expense | $21.5M | +41.9% |
| Pre-tax Income | -$66.0M | +64.8% |
| Income Tax | $2.2M | -79.7% |
| Net Income | -$68.2M | +65.6% |
| EPS (Basic) | -$0.49 | +67.5% |
| EPS (Diluted) | -$0.49 | +67.5% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $256.1M | +26.0% |
| Accounts Receivable | $124.6M | +35.8% |
| Current Assets | $677.9M | +30.7% |
| Total Assets | $823.8M | +23.2% |
| Current Liabilities | $279.4M | -10.3% |
| Long-term Debt | $359.5M | +70.9% |
| Total Liabilities | $690.1M | +20.8% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.8M | +9.1% |
| Capital Expenditures | $10.0M | -6.1% |
| Investing Cash Flow | -$84.3M | +35.7% |
| Financing Cash Flow | $156.5M | -35.3% |
| Free Cash Flow | -$28.8M | +8.1% |
| Stockholders' Equity |
| $133.7M |
| +37.6% |